IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
+16.64%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$762M
AUM Growth
+$762M
(+58%)
Cap. Flow
+$253M
Cap. Flow
% of AUM
33.18%
Top 10 Holdings %
Top 10 Hldgs %
36.2%
Holding
102
New
30
Increased
25
Reduced
12
Closed
27
Top Buys
| 1 |
Cigna
CI
|
$50.5M |
| 2 |
Zimmer Biomet
ZBH
|
$43.7M |
| 3 |
McKesson
MCK
|
$30.8M |
| 4 |
Tenet Healthcare
THC
|
$18.9M |
| 5 |
Boston Scientific
BSX
|
$17M |
Top Sells
| 1 |
Stryker
SYK
|
$14.3M |
| 2 |
Teleflex
TFX
|
$11.7M |
| 3 |
Cardinal Health
CAH
|
$11.5M |
| 4 |
Biogen
BIIB
|
$11.1M |
| 5 |
uniQure
QURE
|
$10.1M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Aclaris Therapeutics
ACRS
$223M
| – | – |
-225,000
| Closed | -$1.82M |
|
77
Agios Pharmaceuticals
AGIO
$2.36B
| – | – |
-213,000
| Closed | -$4.89M |
|
78
Align Technology
ALGN
$9.59B
| – | – |
-22,000
| Closed | -$7.35M |
|
79
Baxter International
BAX
$12.1B
| – | – |
-200,000
| Closed | -$8.11M |
|
|
80
Biogen
BIIB
$20.5B
| – | – |
-40,000
| Closed | -$11.1M |
|
|
81
Cardinal Health
CAH
$36B
| – | – |
-152,000
| Closed | -$11.5M |
|
82
FibroGen
FGEN
$48.4M
| – | – |
-4,080
| Closed | -$1.9M |
|
83
GoodRx Holdings
GDRX
$1.49B
| – | – |
-203,000
| Closed | -$1.27M |
|
84
Humana
HUM
$37.5B
| – | – |
-20,000
| Closed | -$9.71M |
|
85
Idexx Laboratories
IDXX
$50.7B
| – | – |
-20,000
| Closed | -$10M |
|
86
iRhythm Technologies
IRTC
$5.67B
| – | – |
-30,000
| Closed | -$3.72M |
|
|
ITOS
87
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-180,000
| Closed | -$2.45M |
|
88
Merck
MRK
$210B
| – | – |
-90,000
| Closed | -$9.58M |
|
89
Moderna
MRNA
$9.36B
| – | – |
-35,000
| Closed | -$5.38M |
|
90
Merus
MRUS
$5.04B
| – | – |
0
| – | – |
|
91
Natera
NTRA
$23B
| – | – |
-75,000
| Closed | -$4.16M |
|
92
Nuvalent
NUVL
$5.74B
| – | – |
0
| – | – |
|
93
Novo Nordisk
NVO
$252B
| – | – |
0
| – | – |
|
94
Option Care Health
OPCH
$4.7B
| – | – |
-101,000
| Closed | -$3.21M |
|
|
95
uniQure
QURE
$954M
| – | – |
-500,000
| Closed | -$10.1M |
|
96
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-3,000
| Closed | -$2.47M |
|
97
The Beauty Health Co
SKIN
$254M
| – | – |
-152,000
| Closed | -$1.92M |
|
98
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
0
| – | – |
|
|
99
Stryker
SYK
$149B
| – | – |
-50,000
| Closed | -$14.3M |
|
|
100
Teleflex
TFX
$5.57B
| – | – |
-46,000
| Closed | -$11.7M |
|